UK initiative aims to cut COVID-19 drug development to a few weeksA new UK trial initiative aims to cut the design phase of clinical studies for potential COVID-19 drugs from around 18 Share XUK initiative aims to cut COVID-19 drug development to a few weekshttps://pharmaphorum.com/news/uk-initiative-aims-to-cut-covid-19-drug-development-to-a-few-weeks/
Unlocking health data to improve oncology outcomesThe NHS’ globally unique health data ecosystem has the potential to improve health outcomes. With around 363,000 new Share XUnlocking health data to improve oncology outcomeshttps://pharmaphorum.com/oncology/unlocking-health-data-to-improve-oncology-outcomes/
COVID-19 patient registry could inform lockdown exit strategyRecruitment for a patient registry app for COVID-19 is underway, which could help governments find their way out Share XCOVID-19 patient registry could inform lockdown exit strategyhttps://pharmaphorum.com/news/covid-19-patient-registry-aims-to-h/
An innovative approach to improving research and patient care with NHS dataUnderstanding how patients are treated in routine clinical care has great potential to improve treatment and enrich academic Share XAn innovative approach to improving research and patient care with NHS datahttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/improving-research-patient-care-nhs-data-iqvia/
Demonstrating the value of RWEA new cross-industry effort hopes to research the benefits of RWE and promote acceptance of alternatives to traditional Share XDemonstrating the value of RWEhttps://pharmaphorum.com/views-analysis-oncology/demonstrating-the-value-of-rwe/
Launch excellence in a disrupted worldThe accelerating speed of change within the pharmaceutical launch environment raises considerable challenges for launch excellence, as companies Share XLaunch excellence in a disrupted worldhttps://pharmaphorum.com/views-analysis-sales-marketing/launch-excellence-in-a-disrupted-world/
How new technologies are creating new marketsSarah Rickwood looks at why the next frontier for pharmaceutical innovation may not be a pharmaceutical at all, Share XHow new technologies are creating new marketshttps://deep-dive.pharmaphorum.com/magazine/sales-and-marketing-2019/how-new-technologies-are-creating-new-markets-iqvia-launch/
IQVIA launches UK cancer database amid survival rate concernAs figures show the UK continues to lag behind other developed countries in cancer survival, a new project Share XIQVIA launches UK cancer database amid survival rate concernhttps://pharmaphorum.com/news/iqvia-launches-uk-national-cancer-database-amid-concerns-over-survival-rates/
Achieving launch excellence in orphan medicinesNew rare disease treatments face a complex market access landscape that presents fundamental challenges for pharmaceutical companies seeking Share XAchieving launch excellence in orphan medicineshttps://pharmaphorum.com/market-access-2/achieving-launch-excellence-in-orphan-medicines/
